Pooled analysis showed, ALT levels were elevated in 16.00% (95% CI = 14.00-18.00) of patients with non-severe COVID-19 and in up to 25.00% (95% CI = 20.00-31.00) of patients with severe COVID-19. This evidence concerns the gene GPT and COVID-19.